<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F0FAFA8C-6DC4-42D4-92BF-BD650E147FD6"><gtr:id>F0FAFA8C-6DC4-42D4-92BF-BD650E147FD6</gtr:id><gtr:name>International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F0FAFA8C-6DC4-42D4-92BF-BD650E147FD6"><gtr:id>F0FAFA8C-6DC4-42D4-92BF-BD650E147FD6</gtr:id><gtr:name>International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3B7B1332-9A39-42D5-A35C-C27E2B7BBEAF"><gtr:id>3B7B1332-9A39-42D5-A35C-C27E2B7BBEAF</gtr:id><gtr:firstName>Momodou</gtr:firstName><gtr:surname>Jasseh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1003%2F1"><gtr:id>C04D55D8-3AEB-4B74-A257-417AC4324666</gtr:id><gtr:title>Basse Health and Demographic Surveillance System</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1003/1</gtr:grantReference><gtr:abstractText>By virtue of the size of the population it covers, the Basse HDSS offers opportunities to understand the dynamics and risk factors associated with common infectious diseases prevailing in a typical Sub-Saharan African setting characterised by poverty and limited access to health care facilities and services. Prospective follow up of the population through 4-monthly household demographic (and biennial socio-economic) updates determines the trends in the death rate in different age groups of the population; and the conduct of verbal autopsies for as many deaths as possible ascertains the probable causes of death. The process therefore enhances our understanding of the health and socio-economic factors that that drive and sustain the determinants of disease-specific morbid episodes and mortality, especially infectious diseases among children.</gtr:abstractText><gtr:technicalSummary>The Basse Health and Demographic Surveillance System (BHDSS) was established in July 2007, primarily to support Basse?s participation in the Global Enteric Multicentre Study (GEMS) and the ongoing Pneumococcal Surveillance Project (PSP). It covers a population of about 170,000 in 219 settlements in the Fulladu East and Kantora Districts of the Upper River Region of The Gambia, a setting typical of much of rural Sub-Saharan and with a high burden of communicable and preventable diseases. In addition to the GEMS and PSP projects, it hosts and facilitates the implementation of a range of other projects and studies.
The BHDSS, with a similar operational design as the Farafenni HDSS, constitutes a potential valuable resource to establish benchmarks and monitor progress towards the achievement of post-2015 global and regional health indicators that the international community will be expected to set.
Specific strategies to be adopted to maximise the scientific output of the BHDSS include:
? Potential linkage of DSS data with Basse Major Health Centre records (in recognition of its potential upgrading to a District Hospital), thus broadening the scope for medical research to include, among other things, disease-specific morbidity burden estimation for both communicable and non-communicable diseases, and their respective impact on quality of life.
? Enhance capacity to support the placement of PhD students in the fields of Demography, Epidemiology, Sociology, etc, and build multi-disciplinary capacity for optimal utilisation of the data generated by the platform.
? Fully engage government stakeholders in the utilisation of the platform database to inform public health policy formulation and review; as well as generating the necessary evidence base required to guide rational health care delivery planning and resource allocation.</gtr:technicalSummary><gtr:fund><gtr:end>2018-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-02</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1324106</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Department of Immunization, Vaccines and Biologicals</gtr:department><gtr:description>WHO Ad Hoc Expert consultation on Non-Specific Effects of Vaccines</gtr:description><gtr:id>E96BAFE8-2B71-4F88-8DF1-09B7E8083CD0</gtr:id><gtr:impact>Draft research protocol on randomized controlled trials of early versus late BCG vaccination. It is yet to be finalised and submitted to the WHO SAGE advisory committee for consideration and approval.</gtr:impact><gtr:outcomeId>58c88397a598b7.39135178-1</gtr:outcomeId><gtr:partnerContribution>Cover travel and board for all meetings I have attended.</gtr:partnerContribution><gtr:piContribution>Participation in a series of workshops to develop a multi-site research protocol to investigate the impact of BCG on survival in the first 14 weeks of life, as well as in infancy. The Basse Health and Demographic Surveillance System is being put forward for consideration as a potential study site.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Rationale for a Vaccine efficacy trial during Public Health Emergencies</gtr:description><gtr:id>25F4B146-6873-4220-8D35-829E3321507D</gtr:id><gtr:impact>Work is still progressing on the WHO R&amp;amp;D blueprint for action to prevent epidemics.</gtr:impact><gtr:outcomeId>58c88aa4b74ab1.55510678-1</gtr:outcomeId><gtr:partnerContribution>Facilitation of my participation in all meetings and consultations.</gtr:partnerContribution><gtr:piContribution>Participation in a series of meetings aimed at developing a clinical toolbox for vaccine trials during public health emergencies.

Oral presentation at a joint WHO &amp;amp; NIAID (USA) Scientific Consultation on Zika Virus Vaccine Development, explaining the process adopted to develop the WHO R&amp;amp;D blueprint for action to prevent epidemics.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Cause of Death Determination</gtr:description><gtr:id>F05240C3-8F5A-49BB-9912-48C1D58932A3</gtr:id><gtr:impact>International seminar presentations.</gtr:impact><gtr:outcomeId>ap9fGqAJHeo-1</gtr:outcomeId><gtr:partnerContribution>Development of a computer algorithm (InterVA) to interpret verbal autopsies.

Development of standard verbal autopsy questionnaires.</gtr:partnerContribution><gtr:piContribution>Contribute Farafenni cause-of-death data for multi-site studies.

Co-ordinated the analysis of HIV-attributable mortality in adults in four West African HDSS sites using verbal autopsy data.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Health Metrics Network (HMN)</gtr:department><gtr:description>Cause of Death Determination</gtr:description><gtr:id>AA80DE12-B086-4F84-A3CF-67A9E510A150</gtr:id><gtr:impact>International seminar presentations.</gtr:impact><gtr:outcomeId>ap9fGqAJHeo-2</gtr:outcomeId><gtr:partnerContribution>Development of a computer algorithm (InterVA) to interpret verbal autopsies.

Development of standard verbal autopsy questionnaires.</gtr:partnerContribution><gtr:piContribution>Contribute Farafenni cause-of-death data for multi-site studies.

Co-ordinated the analysis of HIV-attributable mortality in adults in four West African HDSS sites using verbal autopsy data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>10066C19-BD47-45C6-8DF4-952F4BC0AA73</gtr:id><gtr:title>Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91ed8fbc4f7229b333b42393e35226ed"><gtr:id>91ed8fbc4f7229b333b42393e35226ed</gtr:id><gtr:otherNames>Mackenzie GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>56ddd0c53f9933.00112318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1001368F-D3D6-4DC4-A8EF-47FD3D2ADA36</gtr:id><gtr:title>Spatial analysis of under-5 mortality and potential risk factors in the Basse Health and Demographic Surveillance System, the Gambia.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e545269c6c7b0aabe4af913177c31c9e"><gtr:id>e545269c6c7b0aabe4af913177c31c9e</gtr:id><gtr:otherNames>Quattrochi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>56ddd0c56d1bd9.26578968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B53FDE10-30D6-4527-A16E-2A87B006E864</gtr:id><gtr:title>Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91ed8fbc4f7229b333b42393e35226ed"><gtr:id>91ed8fbc4f7229b333b42393e35226ed</gtr:id><gtr:otherNames>Mackenzie GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>58c85aa23d1262.62830416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A11228D-6475-418D-857C-008A6ACB38B0</gtr:id><gtr:title>Serogroup W135 meningococcal disease, The Gambia, 2012.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16027f09a1b1e435dac44e980eb7c9a1"><gtr:id>16027f09a1b1e435dac44e980eb7c9a1</gtr:id><gtr:otherNames>Hossain MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>doi_15225_909_130077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>736E7CAB-6EE6-476E-9628-94654B50B0F5</gtr:id><gtr:title>High genotypic diversity among rotavirus strains infecting Gambian children.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb6b48c6512eda568e8c90771ddf7e7"><gtr:id>5bb6b48c6512eda568e8c90771ddf7e7</gtr:id><gtr:otherNames>Kwambana BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>5460ef247c3650.70218497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7D4EA2B-B657-4AB3-A6BD-80FF5400853D</gtr:id><gtr:title>Child Mortality after Discharge from a Health Facility following Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort Study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c34dd75d47072d5225383b4e90693ff7"><gtr:id>c34dd75d47072d5225383b4e90693ff7</gtr:id><gtr:otherNames>Chhibber AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56ddd0c51bf726.96824233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E14845E5-EA6F-481F-823B-63E904A73DBE</gtr:id><gtr:title>Health Care Utilization and Attitudes Survey: understanding diarrheal disease in rural Gambia.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dfbbe8d2979494bf009c55461203c75"><gtr:id>6dfbbe8d2979494bf009c55461203c75</gtr:id><gtr:otherNames>Saha D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>doi_15225_mh_12_0751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF42CB66-099E-416C-A425-3FE18D45D7D5</gtr:id><gtr:title>Coverage and timing of children's vaccination: an evaluation of the expanded programme on immunisation in The Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41a1121db9f971503c2bd7f8fa4d4247"><gtr:id>41a1121db9f971503c2bd7f8fa4d4247</gtr:id><gtr:otherNames>Scott S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460ef24cbf8c4.12956676</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1003/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>